PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 142 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $200 | -39.6% | 12,000 | 0.0% | 0.04% | -37.3% |
| Q2 2023 | $331 | +19.9% | 12,000 | 0.0% | 0.07% | +9.8% |
| Q1 2023 | $276 | +15.0% | 12,000 | -45.5% | 0.06% | +7.0% |
| Q4 2022 | $240 | -99.9% | 22,000 | 0.0% | 0.06% | +21.3% |
| Q3 2022 | $185,000 | +6.3% | 22,000 | 0.0% | 0.05% | +11.9% |
| Q2 2022 | $174,000 | -66.6% | 22,000 | 0.0% | 0.04% | -58.8% |
| Q1 2022 | $521,000 | -30.7% | 22,000 | 0.0% | 0.10% | -27.1% |
| Q4 2021 | $752,000 | +92.8% | 22,000 | 0.0% | 0.14% | +75.0% |
| Q3 2021 | $390,000 | -60.5% | 22,000 | 0.0% | 0.08% | -60.4% |
| Q2 2021 | $987,000 | +73.2% | 22,000 | 0.0% | 0.20% | +57.8% |
| Q1 2021 | $570,000 | +28.4% | 22,000 | 0.0% | 0.13% | +23.1% |
| Q4 2020 | $444,000 | +3.3% | 22,000 | 0.0% | 0.10% | -7.1% |
| Q3 2020 | $430,000 | +10.5% | 22,000 | 0.0% | 0.11% | -1.8% |
| Q2 2020 | $389,000 | +151.0% | 22,000 | 0.0% | 0.11% | +70.1% |
| Q1 2020 | $155,000 | 0.0% | 22,000 | 0.0% | 0.07% | +63.4% |
| Q4 2019 | $155,000 | -24.0% | 22,000 | +29.4% | 0.04% | -30.5% |
| Q3 2019 | $204,000 | -1.0% | 17,000 | 0.0% | 0.06% | -4.8% |
| Q2 2019 | $206,000 | -15.9% | 17,000 | -12.8% | 0.06% | -19.5% |
| Q1 2019 | $245,000 | +25.6% | 19,500 | -32.8% | 0.08% | +8.5% |
| Q4 2018 | $195,000 | – | 29,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $56,331,209 | 18.32% |
| Kynam Capital Management, LP | 1,375,000 | $31,625,000 | 4.08% |
| BVF INC/IL | 3,775,900 | $86,845,700 | 3.18% |
| Cormorant Asset Management, LP | 1,700,000 | $39,100 | 2.58% |
| RTW INVESTMENTS, LP | 4,600,799 | $105,818,377 | 2.20% |
| Ghost Tree Capital, LLC | 225,000 | $5,175,000 | 1.53% |
| 683 Capital Management, LLC | 791,000 | $18,193,000 | 1.36% |
| Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
| Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 105,486 | $2,426,178 | 1.00% |